| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks
1 company
McCulloch Kevin is a See Remarks at XERS. Recent filings cover 1 purchase and 6 sales. Those positions are worth an estimated $15.0M at current prices.
McCulloch Kevin's largest disclosed position is in XERS as See Remarks, worth about $15.0M. The recent filings there lean toward selling, a net 150,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | XERS Xeris Biopharma Holdings, Inc. | See Remarks | Sell | 15,000 | $9.41 | $141,120.00 | -0.9% | - | - | |
| Sep 28, 2026 | XERS Xeris Biopharma Holdings, Inc. | See Remarks | Sell | 25,000 | $10.00 | $250,000.00 | -1.5% | - | - | |
| Sep 1, 2026 | XERS Xeris Biopharma Holdings, Inc. | See Remarks | Sell | 15,000 | $8.49 | $127,308.00 | -0.9% | - | - | |
| Aug 3, 2026 | XERS Xeris Biopharma Holdings, Inc. | See Remarks | Sell | 15,000 | $8.02 | $120,240.00 | -0.9% | - | - | |
| Jul 1, 2026 | XERS Xeris Biopharma Holdings, Inc. | See Remarks | Sell | 90,000 | $8.03 | $722,511.00 | -5.1% | - | - | |
| Jan 8, 2026 | XERS Xeris Biopharma Holdings, Inc. | See Remarks | Sell | 15,000 | $8.00 | $120,000.00 | -0.9% | -27.2% | - | |
| Jun 13, 2025 | XERS Xeris Biopharma Holdings, Inc. | See Remarks | Buy | 25,000 | $4.38 | $109,475.00 | +1.5% | +76.6% | +56.1% |